Along with the appointment of a new chairman, there have been significant changes in the KRPIA’s BOD.

On the 27th, the KRPIA announced that, after Avi BenShoshan, former CEO of MSD Korea, Oh Dong-wook, CEO of Pfizer Korea, was elected as the 14th chairman and will lead the association from February 2021.

The KRPIA plans to newly launch a new board of directors (BOD), such as the Vice Chair and Director.

Sang Pyo Kim, CEO of AstraZeneca Korea and Javed Alam, CEO of Merck Korea, were appointed for the Vice Chair, arising from the appointment of President Oh Dong-wook and the appointment of former GSK Korea CEO to the head office by Julien Samson. Kay Bae, CEO of Sanofi-aven